Agilent Technologies (A) closed at $173.96 on November 13, 2026, up 0.5% from the previous close, on volume of 1,214,966 shares (30-day average 2,004,186).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 29, 2026 | Ratio Put Spread 1 by 2 | 20-Nov-26165[2x] : 180 P | 1,500 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
Agilent to Participate in 9th Annual Evercore Healthcare Conference
Business Wire (Thu, 12-Nov 4:15 PM ET)
Agilent Expands Tumor Profiling Portfolio with SureSelect Cancer Research Pan Heme
Business Wire (Tue, 10-Nov 8:00 AM ET)
Agilent Completes Acquisition of Proscia
Business Wire (Wed, 4-Nov 9:12 AM ET)
Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows
Business Wire (Mon, 2-Nov 8:00 AM ET)
Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
Business Wire (Thu, 29-Oct 4:15 PM ET)
Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
Business Wire (Tue, 27-Oct 8:00 AM ET)
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
Business Wire (Tue, 13-Oct 8:00 AM ET)
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
Business Wire (Thu, 1-Oct 8:00 AM ET)
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
Business Wire (Tue, 29-Sep 8:08 AM ET)
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
Business Wire (Mon, 21-Sep 8:00 AM ET)
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Agilent Technologies trades on the NYSE stock market under the symbol A.
As of November 13, 2026, A stock price climbed to $173.96 with 1,214,966 million shares trading.
A has a beta of 0.60, meaning it tends to be less sensitive to market movements. A has a correlation of 0.06 to the broad based SPY ETF.
A has a market cap of $49.09 billion. This is considered a Large Cap stock.
Last quarter Agilent Technologies reported $2 billion in Revenue and $1.62 earnings per share. This beat revenue expectation by $37 million and exceeded earnings estimates by $.14.
In the last 3 years, A traded as high as $182.99 and as low as $96.43.
The top ETF exchange traded funds that A belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
A has outperformed the market in the last year with a return of +19.1%, while the SPY ETF gained +13.4%. In the last 3 month period, A beat the market returning +16.7%, while SPY returned -2.8%. However, in the most recent 2 weeks A has underperformed the stock market by returning -0.5%, while SPY returned -0.2%.
A support price is $169.38 and resistance is $176.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that A shares will trade within this expected range on the day.
